Indivior Pharmaceuticals Enters Into $175M Accelerated Share Repurchase Agreement With Barclays Bank, Executed Under Indivior's Existing $400M Share Repurchase Program
Indivior Pharmaceuticals, Inc INDV
$36.76
▼ -2.83%
($-1.07)
Open
$37.51
Prev Close
$37.83
Day Range
$36.62 – $37.90
52W Range
$10.63 – $41.00
Market Cap
$4.48B
P/E (TTM)
21.34
Beta
4.27
EPS (TTM)
$1.63
📋 Company Profile
| Industry | Pharmaceuticals |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 2023-06-12 |
| Shares Out. | 121,920,000 |
| Website | indivior.com/ ↗ |
| Phone | 18043791090 |
Indivior Pharmaceuticals, Inc is a publicly traded company under the ticker symbol INDV on the NASDAQ NMS - GLOBAL MARKET, operating in the Pharmaceuticals industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
12 analysts (2026-05-01)